Demand for PHT Corporation Patient-Driven eData Systems Grows 39% in 2013

PHT Corporation achieves strong growth as clinical trials become more patient centric with greater need for patient-driven outcomes

BOSTON & GENEVA--()--PHT Corporation achieved record growth in 2013 with a 39% increase in bookings over 2012. More than 25 pharmaceutical and biotech companies selected the PHT electronic clinical outcome assessment (eCOA) System to collect critical data for 60+ trials and studies. PHT saw strong growth in existing and new therapeutic areas and indications, especially in respiratory, CNS, dermatology and oncology. PHT added 6 new clients through direct sales and CRO partnerships and continues to lead as the trusted provider of electronic systems for patient-driven outcomes.

PHT President and CEO Philip Lee attributes the strong 2013 performance to PHT aligning corporate strategy and focus on customer success: “PHT is 100% committed to client satisfaction and success. In 2013, PHT invested in the right mix of products, people and processes to strengthen customer relationships and deliver greater value and service on every project.”

Allergopharma GmbH leveraged PHT Clinical Science & Consulting Services and describes the experience of working with the PHT team: “The Allergopharma team is very pleased with the timely conduct of the whole project. We are looking forward to working with PHT on the first implementation of the new eDiary into a clinical trial,” said Dr. Kirsten Plueckhahn, Clinical Project Manager.

Looking toward another strong year, PHT Vice President of Marketing and Product Management Sheila Rocchio said, “In 2014 PHT sees 3 key trends: the widespread use of ‘Apps’ on the latest devices enabling ‘bring your own device’ options, the continued adoption of eCOA systems with more trials and programs using eCOA by sponsors and CRO partners and an expanded PHT product suite and services focused on the patient and eSource capabilities that improves sponsors ROI.”

New Products – In 2013, PHT launched the LogPad App®, a mobile app that collects clinical research data on the latest smartphones; and MyStudyHome™, an online community that keeps clinical research sites engaged and compliant with training and documentation, calendars, and study specific updates.

Expanded Clinical Science and Consulting Services – Clinical Science and Consulting quadrupled revenue growth over last year with the strongest demand for instrument development, patient testing and meetings with the FDA. Watch this video and learn more about the PHT Clinical Science and Consulting Team http://bit.ly/1a5t9v1

Industry Recognition – For the second consecutive year Phil Lee was a finalist for the Ernst & Young New England Entrepreneur of the Year award. Phil also was a finalist for the second time for the international SCRIP Executive of the Year award. PHT was named one of New England’s 100 largest private companies by the Boston Business Journal and earned a place on the Inc. 5000 for the third year. PHT was nominated in 4 categories in the Massachusetts Technology Leadership Council Awards Program and won for Best Recruiting Video http://bit.ly/WhoIsPHT.

Join the next PHT educational webinar “Effective Use, Analysis, and Best Practices of eCOA Data Capture for Inflammation and Arthritis ResearchFebruary 12.

To hear case studies, innovations and best practices for PROs and eCOA Systems register for the 2014 PRO & eCOA Congress at bit.ly/16EYVSg. PHT invites all Congress alumni to join the PRO & eCOA Congress LinkedIn Community to exchange information, ideas and experiences.

About PHT Corporation

PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic clinical eCOA Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via StudyWorks™ online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 650+ global trials resulting in 16+ regulatory approvals. PHT Clinical Science and Consulting offers the scientific, regulatory, and technological expertise today’s eCOA market demands and patients deserve. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter, Google+ and YouTube.

Contacts

For PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com

Release Summary

In 2013 patient-driven eData systems innovator PHT Corporation increased bookings by 39% over 2012 as 25+ pharma and biotech companies selected the PHT eCOA System for 60+ clinical trials and studies.

Sharing

Contacts

For PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com